Vantal

Quick links to important sections

Vantal

Method of action: Local Anesthetic, Stomatological

Treatment option: Bacterial Vaginosis

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vantal

Property Description
Active Ingredient Benzydamine Hydrochloride
Form Oromucosal Solution, Oromucosal Spray
Pharmacological Class Non-steroidal Anti-inflammatory Drug (NSAID) Derivative, Local Analgesic
Common Use Targeted relief of localized pain and inflammation in the mouth and throat
Origin Synthetic Compound (Indazole Derivative)

What Type of Medicine is Vantal (Benzydamine)?

Vantal is a medication based on the active compound Benzydamine, which is a synthetic indazole derivative. Pharmacologically, it is classified as a Non-steroidal Anti-inflammatory Drug (NSAID) derivative that is specifically formulated for local action. Benzydamine’s unique structure allows it to accumulate in the mucosal tissues where it is applied, a property recognized for maximizing targeted relief while minimizing systemic exposure, distinguishing it from traditional oral NSAIDs. Benzydamine is a recognized topical treatment for local anti-inflammatory and analgesic effects. The medicine is formulated to help ease discomfort by reducing pain and local swelling right where it’s applied.

Composition, Form, and General Purpose

Vantal is a single active ingredient product in which the therapeutic agent is Benzydamine Hydrochloride. It is typically presented in liquid forms, such as an oromucosal solution (gargle or mouthwash) and an oromucosal spray, designed for oromucosal administration. This focus on topical liquid forms positions Vantal for direct application to the soft tissues of the throat and mouth. The general purpose of this topical application is to directly address localized discomfort through a dual mechanism: it functions as an anti-inflammatory agent to help reduce swelling, and it possesses local anesthetic properties to provide numbing relief. Benzydamine is recognized for its ability to stabilize cell membranes and inhibit the local production of pro-inflammatory substances. This mechanism works by stabilizing the affected cells and targeting the chemical triggers of swelling.

What side effects are possible with Vantal?

Possible Side Effects and Safety Information

This section outlines the adverse effects and safety constraints for topical Benzydamine Hydrochloride (Vantal), as documented in official government regulatory documents (such as the Summary of Product Characteristics, SmPC, and FDA Prescribing Information).

Documented Adverse Reactions

The most common adverse effects are local sensations at the site of application. Regulatory documents classify side effects by frequency:

Classification Examples of Side Effects
Uncommon (1 in 1,000 to 1 in 100) Oral numbness, Stinging feeling in the mouth, Photosensitivity reaction
Rare (1 in 10,000 to 1 in 1,000) Dry mouth, Nausea, Vomiting
Very Rare (less than 1 in 10,000) Bronchospasm, Laryngospasm, Rash, Urticaria
Frequency Not Known Hypersensitivity reactions, Anaphylactic reaction, Angioedema

Serious adverse reactions, though classified as Very Rare or Frequency Not Known, include the potential for anaphylactic reaction and respiratory events like bronchospasm, which affect the Immune and Respiratory System Organ Classes, respectively.

Regulatory Safety Considerations

The official labeling includes specific restrictions and cautions:

  • Contraindications: The medicine is strictly contraindicated for individuals with known hypersensitivity to the active compound, Benzydamine Hydrochloride, or any of the excipients.
  • Asthma and NSAID Sensitivity: Caution is required in patients with a history of bronchial asthma or sensitivity to other Non-steroidal Anti-inflammatory Drugs (NSAIDs), as use may precipitate bronchospasm.
  • Pregnancy and Lactation: Use during pregnancy or while breastfeeding is generally not recommended or should be considered essential by a healthcare professional.
  • Treatment Duration: The local stinging sensation has been reported to disappear upon continuation of treatment. However, long-term use may increase the risk of sensitization (allergic reactions).

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Vantal (Benzydamine) is primarily associated with systemic toxicity following the accidental swallowing of large volumes of the oromucosal solution or spray. While small quantities of accidental ingestion are generally considered harmless, official regulatory documents describe specific symptom profiles and required emergency actions for excessive exposure.

Overdose manifestations relate chiefly to Central Nervous System (CNS) excitation and Gastrointestinal (GI) disturbances. CNS symptoms may include agitation, restlessness, dizziness, optical hallucinations, and potentially convulsions or loss of coordination (ataxia). Gastrointestinal effects often involve nausea, vomiting, and abdominal pain. In very large ingestions, severe outcomes such as tachycardia (rapid heart rate), fever, and the potential for respiratory paralysis are documented.

Immediate medical attention is required if a large amount of Vantal is accidentally swallowed or if any overdose symptoms are observed. Regulators specifically note that children are at risk for systemic symptoms, such as convulsions, following accidental ingestion. Management protocols confirm that no specific antidote is known; therefore, treatment is symptomatic and supportive, and may include procedures like gastric lavage to remove the unabsorbed drug.

Therapeutic Uses of Vantal

Quick Facts

  • Relieves: Discomfort in the mouth and throat (oral and pharyngeal cavities).
  • May be used to assist with: Managing symptoms associated with pharyngitis, tonsillitis, gingivitis, and stomatitis.
  • Common Contexts: Symptomatic care following dental and oral surgical procedures.

What Vantal Treats: Main Uses and Benefits

Vantal is indicated to assist in the symptomatic relief of discomfort in the oral and pharyngeal region. It is employed to manage a range of conditions that involve the mucous membranes of the mouth and throat.

Clinical experience suggests Vantal is a suitable option for providing care for individuals experiencing symptoms of inflammation and irritation in these areas, which may occur with common issues like sore throat and tonsillitis. Additionally, its use is supported in contexts involving the care of the oral cavity, such as following minor dental and oral surgical procedures, including tooth extractions and implantology.

The medication serves a role in addressing symptoms associated with oral inflammatory conditions such as gingivitis (gum inflammation), stomatitis (mouth inflammation), and mucositis. The therapeutic objective is to contribute to patient comfort during the management of these conditions.

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

The eligibility for using Vantal is strictly defined by regulatory documents, focusing on absolute contraindications and conditional use requirements across different populations.

Population Status Official Regulatory Rule
Contraindicated Populations Individuals with known hypersensitivity to benzydamine hydrochloride or any of its ingredients. The product is also contraindicated for those with a history of allergy to acetylsalicylic acid or other NSAIDs due to the risk of cross-sensitivity.
Conditional Use/Caution Caution is required in patients with a history of Bronchial Asthma due to the potential for bronchospasm. Caution is also advised for patients with renal impairment or hepatic impairment (Source 3.2).
Age-Related Eligibility Use is permitted for Adults and the Elderly. The minimum eligible age varies by formulation: the oromucosal spray may be used in children as young as 6, while the oromucosal solution (mouthwash) is generally not recommended for children under 12 years of age.
Reproductive Status Use is not recommended during pregnancy unless deemed clearly necessary by a physician, and is generally contraindicated in later stages. The medicine is also not recommended during breastfeeding due to insufficient data on excretion into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Vantal (Benzydamine) is characterized by its localized administration as an oromucosal solution or spray, which results in minimal systemic absorption of the active ingredient. Consequently, regulatory authorities have determined that the risk for systemic drug-drug interactions is low. All interaction information is defined by the status of observed systemic interaction studies.


Interaction Scope

Interaction Entity Category Official Regulatory Documentation
Systemic Interactions (Pharmacokinetic/Pharmacodynamic) None documented.
Food, Alcohol, Herbal Products None documented.
Timing/Separation Requirements None documented.

Interaction Classifications

Classification Official Regulatory Documentation
Interaction Severity Classification Not classified; no formal systemic interactions are documented.
Interaction-Related Restrictions None documented.

Resulting Interaction Structure

Official regulatory labels consistently state that no interactions have been observed in performed human studies for the topical formulation of Benzydamine. Furthermore, official prescribing information does not list any specific medicinal products that are formally contraindicated for co-administration due to an interaction risk. There are no mandatory timing rules or separation requirements for administration relative to other medicines, as no specific pharmacokinetic or pharmacodynamic interaction mechanisms have been documented to affect Vantal's clearance or exposure.

Mechanism of Action

How Vantal Works

Vantal exerts its effects by selectively modulating key signaling pathways that influence cellular excitability and signaling patterns. Its mechanism involves targeted engagement with specific receptors and enzymes, leading to a modified adjustment in systemic physiological outcomes. The drug's action can be divided into distinct mechanistic domains:


Modulating Receptor-Mediated Signaling

Vantal primarily acts within domains involving receptor-mediated signaling by binding to specific receptor subtypes on cell surfaces. This action initiates or suppresses signaling sequences that modify early molecular steps, thereby altering the activity of systems where specific transmitters or mediators dominate. This engagement results in the modulation of downstream signaling activity.


Regulating Key Enzyme Pathways

The drug also engages mechanisms that involve the modulation of key enzyme pathways. By influencing these enzymatic targets, Vantal supports the regulation of processes driven by distinct signaling patterns. This interaction reduces the net output of specific mediator activity, leading to a modified state of pathway activation, particularly relevant in cascades where multiple layers of pathway activation occur.


Influencing Pathway Feedback Regulation

Vantal's mechanism influences systems through the modulation of feedback regulation within specific pathways. It supports the alteration of pathway activity that may occur under certain conditions, engaging mechanisms that modulate dysregulated processes. This influences downstream cellular activity, contributing to the overall systemic action of the compound.

Dosage and Administration Information

How to Use Vantal (Cefpodoxime Proxetil) — Administration Guidelines

This information describes the administration and dosing of Vantal (Cefpodoxime Proxetil), which is a cephalosporin antibiotic.


Administration Scope

Component Instruction
Route of administration Oral (by mouth) only.
Dosing schedule Typically 100 mg to 400 mg per dose for adults, or 5 mg/kg per dose for pediatric patients (2 months to 12 years). Doses are expressed as cefpodoxime active moiety.
Frequency pattern Standard frequency is twice daily (every 12 hours) for most indications. A single dose is used for certain specific infections.
Timing in relation to meals Tablets must be taken with food to maximize absorption. Oral Suspension may be taken with or without food (though absorption is enhanced with food).

Preparation and Procedural Conditions

Oral Suspension Preparation: Granules for oral suspension must be reconstituted with water according to package instructions. The suspension must be shaken well immediately before each use to ensure the medication is evenly mixed and the patient receives the correct dose.

Special Conditions (Renal Impairment): Dosage adjustments are required for patients with reduced kidney function. For individuals with a creatinine clearance below 30 mL/min, the standard dosing interval is extended to once every 24 hours. For patients on hemodialysis, the usual dose is administered three times per week, after hemodialysis.

Missed Dose Instructions: If a dose is missed, take it as soon as it is remembered. If it is almost time for the next scheduled dose, skip the missed one and continue the regular schedule. Do not double the dose to make up for a missed one.

Recent Clinical Evidence

Vantal: Recent Clinical Evidence

The clinical evidence for Vantal (Benzydamine) has been evaluated across various research settings, primarily focusing on its local application for pain and inflammation in the mouth and throat. Drawing from Randomized Controlled Trials (RCTs), systematic reviews, and authoritative guidelines, the available research describes patterns observed in specific conditions.


Research on Symptom Relief for Acute Sore Throat

Short-term, double-blind RCTs have examined Vantal's application in adult populations with acute sore throat. Studies monitored outcomes related to physical discomfort, and findings describe patterns where reported pain relief occurred earlier in groups that received Vantal compared to placebo. However, follow-up durations were limited to the acute phase, and there is limited information for long-term outcomes.


Evidence in Surgical and Supportive Care Contexts

Research has explored Vantal's use in managing discomfort following surgical procedures, such as sore throat after intubation. Systematic reviews indicate that its use as a pre-procedure gargle was associated with a reduced incidence of postoperative discomfort.

Furthermore, Benzydamine has been studied in supportive cancer care. Research utilized RCTs and formal clinical guidelines to monitor its role in the prevention of severe mouth inflammation (oral mucositis) in patients undergoing radiation therapy. Findings describe patterns where its use was associated with a lower recorded incidence of this specific complication. Data for certain groups remain insufficient when evaluating its role in treating established severe inflammation.


Research Gaps

Research primarily focuses on acute episodes in adults. Data for certain groups remain insufficient, including specific research for older adults or patients with defined comorbidities. Evidence is limited in contexts that require long-term data, and findings for various other inflammatory conditions, such as stomatitis, were mixed or heterogeneous due to varied study designs.

Key Studies & References

  1. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
  2. Effective evaluation of benzydamine hydrochloride as a mouth wash in subjects with plaque induced gingival inflammation

Frequently Asked Questions (FAQ)

Common questions about Vantal (FAQ)


Q: What is the main difference between Vantal and other similar medicines?

Official information describes Vantal's active ingredient as a non-steroidal anti-inflammatory drug (NSAID) derivative. The key distinction is that it is formulated for local use in the mouth and throat. This targeted application is intended to result in minimal absorption into the rest of the body, distinguishing it from NSAIDs taken orally for systemic effects.


Q: Is Vantal the same kind of medicine as [Common Competitor Name]?

Vantal contains Benzydamine, which is classified as an NSAID derivative, meaning it is related to, but not identical to, traditional oral NSAIDs. It is specially formulated for local action on the mouth and throat, as described in official documents, to minimize widespread systemic exposure.


Q: Can Vantal cause long-term side effects or health problems?

Regulatory documents include a specific caution regarding the duration of use. Official product information notes that long-term use of the product may increase the risk of sensitization, which is a type of allergic reaction. For this reason, official labeling specifies that continuous treatment beyond the recommended period requires professional medical supervision.


Q: Is the risk of side effects higher when first starting Vantal?

Official safety information for Vantal indicates that the local stinging sensation, which is often reported when applying the product, has been reported to disappear upon continuation of treatment. The official documents do not generalize this risk to all side effects.


Q: Is it normal to feel [vague common symptom, e.g., slightly dizzy] when starting Vantal?

Dizziness is not listed among the common side effects of Vantal at recommended use. According to regulatory safety information, it is described as a potential symptom associated only with cases of accidental overdose or, very rarely, as part of a serious allergic reaction.


Q: Does Vantal affect fertility or reproductive health?

Official regulatory documents confirm that animal studies showed no evidence of a teratogenic effect (potential to cause harm to a fetus). Furthermore, no clinical data specifically for the effect on human fertility are available in the official product information.


Q: Can Vantal affect my ability to drive or operate machinery?

Official documents containing safety profiles state that Vantal has negligible influence on the ability to drive or use machinery. This is consistent with its localized action and minimal systemic absorption.


Q: Is Vantal a controlled substance?

Vantal's active ingredient is classified as a non-steroidal anti-inflammatory drug (NSAID) derivative. Consistent with this classification, official schedules and government listings do not include Vantal as a controlled substance.


Q: What does 'bioavailability' mean in the context of Vantal?

Bioavailability refers to the degree and rate at which a substance is absorbed into the bloodstream. In the context of Vantal, regulatory information emphasizes that only a minimal amount of the medicine is absorbed into the general bloodstream, which allows the product to provide its desired local effect primarily in the mouth and throat.


Q: Can Vantal make my existing medical condition worse?

Official regulatory documents require caution for patients with a history of bronchial asthma or sensitivity to other NSAIDs due to the potential for bronchospasm. Caution is also noted for patients with renal (kidney) or hepatic (liver) impairment.


Q: How does the action of Vantal differ from a placebo in studies?

Clinical studies have described that Vantal was associated with a specific benefit compared to a placebo. In trials involving adults with acute sore throat, patterns were observed where Vantal was linked to pain relief occurring earlier than in the groups that received a placebo.


Q: What is Vantal used for besides its primary listed purpose?

Official documentation lists several uses beyond general sore throat relief. These include managing discomfort following dental procedures or oral surgery, and in the prevention of severe mouth inflammation (oral mucositis) in patients undergoing radiation therapy.


Q: How quickly can I expect Vantal to start working?

Due to its localized mechanism of action, the effect of Vantal can be felt shortly after application. Its active component is described in regulatory documents as accumulating rapidly in the inflamed tissues where it is applied.


Q: How long does the effect of one dose of Vantal typically last?

The drug's administration schedule, described in official documents, is typically set for every 1.5 to 3 hours. The pain-relieving effects of Vantal are generally described as lasting for several hours before the next application is typically scheduled.


Q: Can Vantal be used by teenagers or children?

The official eligibility rules vary by the product's formulation. The oromucosal spray may be used in children as young as 6 years old. However, the oromucosal solution (mouthwash) is generally not recommended for children under 12 years of age.


Q: Can I take Vantal if I am taking supplements like vitamins or herbal remedies?

Official regulatory documents define the interaction profile for Vantal. The documentation explicitly states that no systemic interactions have been documented for Vantal with food, alcohol, or herbal products.


Q: Can Vantal cause changes in mood or sleep patterns?

Vantal's list of rare and very rare side effects does not include common changes in mood or sleep patterns. Safety information does report that hallucinations and restlessness have been described as symptoms associated with cases of accidental or excessive overdose.


Q: What should I do if the side effects of Vantal become bothersome?

Regulatory patient information states that if side effects persist or become bothersome, consulting a healthcare professional is recommended.


Q: What is the primary way Vantal is removed from the body (metabolism)?

Official pharmacokinetic information describes that Vantal is primarily removed from the body through metabolism. This occurs through a series of steps that involve oxidation, conjugation, and dealkylation.


Q: Is there a maximum amount of time someone can take Vantal safely?

Official labeling for the mouthwash formulation specifies a recommended duration of use. It advises that uninterrupted treatment should generally not exceed seven days, unless it is being continued under professional medical supervision.


Q: What patient groups were excluded from the main clinical trials for Vantal?

Research evidence themes note that data for certain patient groups remains insufficient in the available studies, including specific research for older adults and patients with defined comorbidities. This means specific data for these groups remains insufficient for a comprehensive assessment.


Q: Does the efficacy of Vantal change with age?

Research evidence themes describe that data for certain groups, including specific research for older adults, remain insufficient for fully assessing the change in efficacy across all age ranges.


Q: Why did the FDA or other agencies approve Vantal for its current use?

The approval for Vantal's current use is based on the body of evidence gathered from clinical trials, including randomized controlled trials. These studies described patterns of benefit and efficacy in the conditions for which the drug is indicated, such as providing earlier pain relief compared to placebo for acute sore throat.

How should Vantal be stored and disposed of?

How to Store and Dispose of Vantal

Storage and disposal instructions for Vantal (Benzydamine) are strictly defined by regulatory documents to maintain its quality and ensure safety.


Official Storage Conditions

Vantal must be stored out of the sight and reach of children and kept at a controlled temperature, typically not exceeding 25°C or 30°C. It is mandatory to protect the product from light by storing it in the original carton. The solution must not be frozen.


In-Use Stability and Disposal

After the bottle is opened, Vantal has a limited in-use period; any remaining product must be discarded after that time (often 6 or 12 months), even if the expiration date has not been reached. Expired or unused medicine must not be disposed of via household waste or wastewater. Instead, it should be returned to a pharmacy for proper disposal according to local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vantal found in:

A-Z Index: